OR WAIT null SECS
London, U.K., and Wilmington, N.C. - Chiltern, a leading global contract research organization, has adopted ePharmaOne™, a proprietary site management platform offered by ePharmaSolutions™, a leading provider of e-clinical solutions. This cloud-based platform improves collaboration with sites, enhances document quality and cycle times, and offers sponsors a paperless, virtual and mobile site management process with an integrated electronic trial master file. “Adding ePharmaOne to our Collaborative Technologies suite brings a new paperless approach necessary to meet regulatory standards and sponsor expectations. We continuously look to strengthen our Collaborative Approach, and this significantly improves the quality of our offerings,” said Jim Esinhart, PhD, Chiltern CEO. “We are excited to support our company focus with yet another way to make clients’ and sites’ jobs easier.” With ePharmaOne, Chiltern clients and sites will have turnkey site document management integrated with a state-of-the-art electronic trial master file (eTMF). This best-in-class technology truly gives Chiltern clients a “Designed Around You” experience. “Chiltern is leading the CRO industry in uptake of technology,” said Alison O’Neill, chief operating officer, ePharmaSolutions. “We are excited they have chosen ePharmaSolutions and are happy to be a part of their portfolio of technologies available to their clients.” The new platform provides an integrated solution for:
Paragon Solutions, a leader in life sciences consulting services, is Chiltern’s implementation partner for ePharmaOne and has been instrumental in driving this implementation project to completion, on time and on budget. Chiltern is scheduling demos in Booth 601 at the Drug Information Association (DIA) Annual Meeting, June 26-30 in Philadelphia. See how this platform can work for your trial by
scheduling a meeting
at the show.
Chiltern, a global contract research organization, is the leading mid-sized provider of clinical solutions in a variety of specialty areas and engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,200, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance, Strategic Regulatory and Clinical Supplies services using a collaborative approach to maximize efficiency and minimize delays. Visit
to learn more about how Chiltern is Designed Around You.